Category Archives: Pr Newswire

BEIJING, June 29, 2024 /PRNewswire/ — NaaS Technology Inc. (Nasdaq: NaaS) (“NaaS” or the “Company”), the first U.S. listed EV charging service company in China, today announces that it has received a notification letter (the “Compliance Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market Inc. (“Nasdaq”) dated June 28, 2024, informing the Company that it […]

BEIJING, June 29, 2024 /PRNewswire/ — Bionic robots that speak both Chinese and English can have the same skin and nails as humans? A flying car powered solely by wind can have a maximum payload of 160 kg? A smart wheelchair can control its operation with just the “mind”? Kevin and Daria, two foreign bloggers, […]

SHANGHAI, June 29, 2024 /PRNewswire/ — From June 26 to 28, 2024, the Mobile World Congress Shanghai (MWC Shanghai) grandly opened at the New International Expo Center. Themed “Future First,” this year’s conference focused on cutting-edge topics such as “5G and Beyond,” “AI Economy,” and “Manufacturing DX.” Under the theme “Dedication, For A Smarter Future”, […]

STOCKHOLM, June 29, 2024 /PRNewswire/ — The Curt Bergfors Foundation is honored to announce that C40 Food Systems, a global network, was awarded the Food Planet Prize, the world’s biggest environmental award, on June 28 in Stockholm, Sweden. This recognition highlights their exceptional contributions and strong potential to transform urban food systems to benefit people […]

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) — Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a commercial-stage ophthalmic company, announced today that it has entered into a securities purchase agreement with an institutional investor and its current largest stockholder, providing for the purchase and sale of 7,575,757 shares of common stock, and warrants to […]

– European Commission decision anticipated in the second half of 2024 – BOSTON, June 28, 2024 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal […]

REDWOOD CITY, Calif., June 28, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of DCCR (diazoxide choline) extended-release tablets for […]

SaaS Healthcare Leader Joins MEDITECH Alliance to Optimize Patient Intake and Payment Processes BOWIE, Md., June 28, 2024 (GLOBE NEWSWIRE) — Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced a new partnership with the MEDITECH Alliance, an ecosystem of partner organizations with successfully proven and interoperable solutions with MEDITECH, a […]

Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announces advancement in its proprietary MEAI- based binge behavior regulator program through the granting of patent approval […]

Announcing Expansion in Brazil with More Portuguese Offerings BEIJING, June 28, 2024 /PRNewswire/ — On June 27, iQIYI, an innovative market-leading online entertainment service in China, concluded its fourth Annual Content Showcase virtually in North America, unveiling an impressive lineup of over 250 new Asian shows. The company also announced the expansion of its operations […]